Clinical trials
Recruiting Phase 2 Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2024 | 1 |
| 2025 | 6 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 2 |
| Novartis Pharmaceuticals | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Alnylam Pharmaceuticals | 1 |
| Eli Lilly and Company | 1 |
| Emory University | 1 |
| Huashan Hospital | 1 |
| Kardigan, Inc. | 1 |
| National Cancer Institute (NCI) | 1 |
| Retension Pharmaceuticals. Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 17 |
| Cardiovascular Diseases | 2 |
| Obesity | 2 |
| Pre-Eclampsia | 2 |
| Renal Insufficiency, Chronic | 2 |
| Atherosclerosis | 1 |
| Atrial Fibrillation | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Heart Murmurs | 1 |
| Hypercholesterolemia | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.